Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
74 hedge funds and large institutions have $724M invested in Enfusion, Inc. in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 11 reducing their positions, and 12 closing their positions.
191% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 11
58% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 12
10% more funds holding
Funds holding: 67 → 74 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less capital invested
Capital invested by funds: $914M → $724M (-$191M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$18.7M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.55M |
| 3 |
ACM
Ararat Capital Management
Westport,
Connecticut
|
+$6.31M |
| 4 |
FC
Franchise Capital
Grand Cayman,
Cayman Islands
|
+$2.12M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.66M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
-$15M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$5.5M |
| 3 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$5.43M |
| 4 |
Millennium Management
New York
|
-$5.22M |
| 5 |
DIG
Dragoneer Investment Group
San Francisco,
California
|
-$5.2M |
ENFN Hedge Fund Activity: Q4 2022 in Review
74 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q4 2022, worth a combined $724M — down 21% from $914M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new ENFN positions and 12 closed out — a net gain of 7 holders — while 32 added to existing stakes and 11 trimmed.
The largest buyer was Brown Capital Management, adding an estimated $18.7M. The largest seller was AllianceBernstein, cutting an estimated $15M.
- 74 institutional investors held Enfusion, Inc. (ENFN) as of Q4 2022, up from 67 in Q3 2022.
- Funds reported $724M of Enfusion, Inc. stock for Q4 2022, down 21% quarter-over-quarter.
- 19 funds opened new Enfusion, Inc. positions in Q4 2022 and 12 closed out, a net change of +7 holders.
- The largest Enfusion, Inc. buyer in Q4 2022 was Brown Capital Management, an estimated $18.7M added.
- The largest Enfusion, Inc. seller in Q4 2022 was AllianceBernstein, an estimated $15M sold.
Based on aggregated 13F filings for Q4 2022.